Phlebologie 2018; 47(05): 272-276
DOI: 10.12687/phleb2422-5-2018
Leitlinie
Georg Thieme Verlag KG Stuttgart · New York

Abstract of the S1-Guideline: Intermittend pneumatic compression (IPK, AIK)

Artikel in mehreren Sprachen: deutsch | English
S. Reich-Schupke
1   Im Namen der Autorengruppe der Leitlinie: Dr. Franz-Xaver Breu, Prof. Dr. Eberhard Rabe, Prof. Dr. Ivo Buschmann, Dr. Walter Döller, Prof. Dr. Gerd Lulay, Dr. Anya Miller, PD Dr. Eva Valesky
,
C. Schwahn-Schreiber
1   Im Namen der Autorengruppe der Leitlinie: Dr. Franz-Xaver Breu, Prof. Dr. Eberhard Rabe, Prof. Dr. Ivo Buschmann, Dr. Walter Döller, Prof. Dr. Gerd Lulay, Dr. Anya Miller, PD Dr. Eva Valesky
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Eingegangen: 04. Juli 2018

Angenommen: 08. Juli 2018

Publikationsdatum:
14. September 2018 (online)

Summary

The intermittend pneumatic compression (IPK, AIK) consists of prophylactic or therapeutic use of alternating pressure for prophylaxis of thrombosis, treatment of edema, improvement of arterial and venous perfusion with reduction of clinical symptoms and improvement of wound healing. IPK can be used in an in- and outpatient setting as well as a home treatment after education of the patient. The equipment consists of a generator and additional cuffs. The devices differ according to indication, localisation of treatment and technical parameters. With correct use and indication, IPK is an effective and safe treatment option. Adverse events are very rare. There is an urgent need for methodical well conducted studies in different indications – except prophylaxis of venous thromboembolia. The protocols should list exact data on the used device (compression and cuffs) and technical parameters (inflation, deflation, plateau, time of break, use per day or week, duration of use).